Broad Institute

Business By Sharon Begley

Monsanto licenses CRISPR technology to modify crops — with key restrictions

In the Lab By Sharon Begley

Subpoena denied: Harvard’s George Church won’t have to testify in CRISPR patent dispute

Exclusive By Sharon Begley

Bold claim of multiple sclerosis gene discovery comes under withering attack

In the Lab By Sharon Begley

In CRISPR patent fight, geneticist George Church may be called to testify

In the Lab By Sharon Begley

Lies, damn lies, and CRISPR: the legal battle escalates

Biotech By Damian Garde and Ed Silverman

With superbug scourge looming, global group bets on biotechs to turn the tide

Biotech By Damian Garde

A lucrative wrinkle in the CRISPR patent fight

In the Lab By Sharon Begley

Scientists solve CRISPR’s ‘Energizer bunny’ problem